Composite active range of motion (CX(A)) and relationship with active function in upper and lower limb spastic paresis

gan Bayle, Nicolas, Maisonobe, Pascal, Raymond, Romain, Balcaitiene, Jovita, Gracies, Jean-Michel
Cyhoeddwyd yn Clin Rehabil (2020)

Factors Influencing Goal Attainment in Patients with Post-Stroke Upper Limb Spasticity Following Treatment with Botulinum Toxin A in Real-Life Clinical Practice: Sub-Analyses from...

gan Fheodoroff, Klemens, Ashford, Stephen, Jacinto, Jorge, Maisonobe, Pascal, Balcaitiene, Jovita, Turner-Stokes, Lynne
Cyhoeddwyd yn Toxins (Basel) (2015)

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longi...

gan Turner-Stokes, Lynne, Ashford, Stephen, Jacinto, Jorge, Maisonobe, Pascal, Balcaitiene, Jovita, Fheodoroff, Klemens
Cyhoeddwyd yn BMJ Open (2016)

Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper l...

gan Kong, Keng He, Balcaitiene, Jovita, Berard, Hugues, Maisonobe, Pascal, Goh, Khean Jin, Kumthornthip, Witsanu, Rosales, Raymond L.
Cyhoeddwyd yn Contemp Clin Trials Commun (2017)

Early AbobotulinumtoxinA (Dysport(®)) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study

gan Rosales, Raymond L, Balcaitiene, Jovita, Berard, Hugues, Maisonobe, Pascal, Goh, Khean Jin, Kumthornthip, Witsanu, Mazlan, Mazlina, Latif, Lydia Abdul, Delos Santos, Mary Mildred D., Chotiyarnwong, Chayaporn, Tanvijit, Phakamas, Nuez, Odessa, Kong, Keng He
Cyhoeddwyd yn Toxins (Basel) (2018)